Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
US5437861A · kind A · utility
46Cited by
17References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1993 |
| Grant date | Aug 1, 1995 |
| Priority date | — |
| Expiry date | Mar 16, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/811
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
This invention provides a composition, device and method for the treatment or prevention of septic shock syndrome or other conditions evidenced by the presence of cytokines in a patient by contacting the patient's whole blood with a composition comprising silica and a surface treatment material, such as heparin, but preferably human serum albumin (HSA). The treatment lowers the cytokine concentration of the blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.